Peripheral and central mechanisms of visceral sensitization in man

Neurogastroenterology and Motility

Volumn 19, Issue SUPPL.1, 2007, Pages 29-46

  Anand, P ^a   Aziz, Q ^b   Willert, R ^b   Van Oudenhove, L ^b,c  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Brain gut axis; Central and peripheral sensitization; Functional gastrointestinal disorders; Psychosocial factors; Visceral hypersensitivity; Visceral pain

Indexed keywords

ACID SENSING ION CHANNEL; ADENOSINE TRIPHOSPHATASE; VANILLOID RECEPTOR 1; VOLTAGE GATED SODIUM CHANNEL;

ABSENTEEISM; ABUSE; ANXIETY; AUTONOMIC NERVOUS SYSTEM; BRAIN SCINTISCANNING; CONFERENCE PAPER; CONSULTATION; DIGESTIVE SYSTEM FUNCTION DISORDER; DYSPEPSIA; HEALTH CARE; HOSPITALIZATION; HUMAN; HYPERSENSITIVITY; HYPOTHESIS; INTESTINE INNERVATION; IRRITABLE COLON; NERVE STIMULATION; NEUROSCIENCE; PAIN ASSESSMENT; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; SENSITIZATION; SENSORY NERVE; SOCIAL PSYCHOLOGY; SOCIOECONOMICS; SPINAL CORD NERVE CELL; STRESS; THORAX PAIN; VISCERAL PAIN;

AUTONOMIC NERVOUS SYSTEM; BRAIN; GASTROINTESTINAL DISEASES; GASTROINTESTINAL TRACT; HUMANS; NEURAL PATHWAYS; PAIN THRESHOLD;

EID: 33846077125     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2006.00873.x     Document Type: Conference Paper

References (206)

1. Talley NJ, Gabriel SE, Harmsen WS, Zinsmeister AR, Evans RW. Medical costs in community subjects with irritable bowel syndrome. Gastroenterology 1997; 109: 1736-41.
2. Fullerton S. Functional digestive disorders (FDD) in the year 2000 - economic impact. Eur J Surg Suppl 1998; 582: 62-4.
3. Mayer EA, Gebhart GF. Basic and clinical aspects of visceral hyperalgesia. Gastroenterology 1994; 107: 271-93.
4. Sarkar S, Aziz Q, Woolf CJ, Hobson AR, Thompson DG. Contribution of central sensitization to the development of non-cardiac chest pain. Lancet 2000; 356: 1154-9.
5. Ritchie J. Pain from distension of the pelvic colon by inflating a balloon in the irritable colon syndrome. Gut 1973; 14: 125-32.
6. Salet GA, Samsom M, Roelofs JM, van Berge Henegouwen GP, Smout AJ, Akkermans LM. Responses to gastric distension in functional dyspepsia. Gut 1998; 42: 823-9.
7. Cook IJ, van Eeden A, Collins SM. Patients with irritable bowel syndrome have greater pain tolerance than normal subjects. Gastroenterology 1987; 93: 727-33.
8. Verne GN, Himes NC, Robinson ME et al. Central representation of visceral and cutaneous hypersensitivity in the irritable bowel syndrome. Pain 2003; 103: 99-110.
9. Blanchard EB, Scharff L, Schwarz SP, Suls JM, Barlow DH. The role of anxiety and depression in the irritable bowel syndrome. Behav Res Ther 1990; 28: 401-5.
10. Locke R, Weaver AL, Joseph Melton L, Talley NJ. Psychosocial factors are linked to functional gastrointestinal disorders: a population based nested casecontrol study. Am J Gastroenterol 2004; 99: 350-7.
11. Mertz H, Pickens D, Fass R, Morgan V. Stress increases sensitivity to rectal distension in IBS but not controls, associated with greater limbic activation. Gastroenterology 2002; 122: A311.
12. Dickhaus B, Mayer EA, Firooz N et al. Irritable bowel syndrome patients show enhanced modulation of visceral perception by auditory stress. Am J Gastroenterol 2003; 98: 135-43.
13. Gue M, Del Rio Lacheze C, Eutamene H, Theodorou V, Fioramonti J, Bueno L. Stress-induced visceral hypersensitivity to rectal distension in rats: role of CRF and mast cells. Neurogastroenterol Motil 1997; 9: 271-9.
14. Stam R, Croiset G, Akkermans LM, Wiegant VM. Sensitization of the colonic response to novel stress after previous stressful experience. Am J Physiol 1996; 271: R1270-3.
15. Geeraerts B, Vandenberghe J, Van Oudenhove L et al. Influence of experimentally induced anxiety on gastric sensorimotor function in man. Gastroenterology 2005; 129: 1437-44.
16. Coutinho SV, Plotsky PM, Sablad M et al. Neonatal maternal separation alters stress-induced responses to viscerosomatic nociceptive stimuli in rat. Am J Physiol Gastrointest Liver Physiol 2002; 282: G307-16.
17. Creed F, Guthrie E, Ratcliffe J et al. Does psychological treatment help only those patients with severe irritable bowel syndrome who also have a concurrent psychiatric disorder? Aust N Z J Psychiatry 2005; 39: 807-15.
18. Drossman DA. Do psychosocial factors define symptom severity and patient status in irritable bowel syndrome? Am J Med 1999; 107: 41S-50S.
19. Al-Chaer ED, Kawasaki M, Pasricha PJ. A new model of chronic visceral hypersensitivity in adult rats induced by colon irritation during postnatal development. Gastroenterology 2000; 119: 1276-85.
20. Spiller RC, Jenkins D, Thornley JP et al. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 2000; 47: 804-11.
21. Spiller RC. Postinfectious irritable bowel syndrome. Gastroenterology 2003; 124: 1662-71.
22. Longstreth GF, Yao J. Irritable bowel syndrome and surgery: a multivariate analysis. Gastroenterology 2004; 126: 1665-73.
23. Gwee KA, Graham JC, McKendrick MW et al. Psychometric scores and persistence of irritable bowel after infectious diarrhoea. Lancet 1996; 347: 150-3.
24. Gwee KA, Leong YL, Graham C et al. The role of psychological and biological factors in postinfective gut dysfunction. Gut 1999; 44: 400-6.
25. Tack J, Bisschops R, Sarnelli G. Pathophysiology and treatment of functional dyspepsia. Gastroenterology 2004; 127: 1239-55.
26. Tack J, Caenepeel P, Fischler B, Piessevaux H, Janssens J. Symptoms associated with hypersensitivity to gastric distention in functional dyspepsia. Gastroenterology 2001; 121: 526-35.
27. Tack J, Piessevaux H, Coulie B, Caenepeel P, Janssens J. Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology 1998; 115: 1346-52.
28. Quigley EMM. Review article: gastric emptying in functional gastrointestinal disorders. Aliment Pharmacol Ther 2004; 20: 56-60.
29. Fischler B, Tack J, De Gucht V et al. Heterogeneity of symptom pattern, psychosocial factors, and pathophysiological mechanisms in severe functional dyspepsia. Gastroenterology 2003; 124: 903-10.
30. Porcelli P, Affatati V, Bellomo A, De Carne M, Todarello O, Taylor GJ. Alexithymia and psychopathology in patients with psychiatric and functional gastrointestinal disorders. Psychother Psychosom 2004; 73: 84-91.
31. Budavari AI, Olden KW. Psychosocial aspects of functional gastrointestinal disorders. Gastroenterol Clin North Am 2003; 32: 477-506.
32. Castillo EJ, Camilleri M, Locke GR, Burton DD, Stephens DA, Geno DM, Zinsmeister AR. A community-based, controlled study of the epidemiology and pathophysiology of dyspepsia. Clin Gastroenterol Hepatol 2004; 2: 985-96.
33. Van Oudenhove L, Demyttenaere K, Tack J, Aziz Q. Central nervous system involvement in functional gastrointestinal disorders. Best Pract Res Clin Gastroenterol 2004; 18: 663-80.
34. Whitehead WE, Palsson O, Jones KR. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications? Gastroenterology 2002; 122: 1140-56.
35. Drossman DA, Camilleri M, Mayer EA, Whitehead WE. AGA technical review on irritable bowel syndrome. Gastroenterology 2002; 123: 2108-31.
36. Locke GR, Lin S-C, Talley NJ. Psychiatric disease and functional GI disorders in the community: more evidence for a casual link? Am J Gastroenterol 2005; 100: 248-9.
37. Naliboff BD, Mayer EA. Brain imaging in IBS: drawing the line between cognitive and non-cognitive processes. Gastroenterology 2006; 130: 267-70.
38. Lydiard RB. Irritable bowel syndrome, anxiety, and depression: what are the links? J Clin Psychiatry 2001; 62 (Suppl. 8): 38-45.
39. Critchley HD, Wiens S, Rotshtein P, Ohman A, Dolan RJ. Neural systems supporting interoceptive awareness. Nat Neurosci 2004; 7: 189-95.
40. Ploghaus A, Tracey I, Gati JS et al. Dissociating pain from its anticipation in the human brain. Science 1999; 284: 1979-81.
41. Keogh E, Cochrane M. Anxiety sensitivity, cognitive biases, and the experience of pain. J Pain 2002; 3: 320-9.
42. Petrovic P, Ingvar M. Imaging cognitive modulation of pain processing. Pain 2002; 95: 1-5.
43. Gregory LJ, Yaguez L, Williams SCR et al. Cognitive modulation of the cerebral processing of human oesophageal sensation using functional magnetic resonance imaging. Gut 2003; 52: 1671-7.
44. Yágüez L, Coen S, Gregory LJ et al. Brain response to visceral aversive conditioning: a functional magnetic resonance imaging study. Gastroenterology 2005; 128: 1819-29.
45. Ochsner KN, Ludlow DH, Knierim K et al. Neural correlates of individual differences in pain-related fear and anxiety. Pain 2006; 120: 69-77.
46. Talley NJ, Howell S, Poulton R. The irritable bowel syndrome and psychiatric disorders in the community: is there a link? Am J Gastroenterol 2001; 96: 1072-79.
47. Blakely RD. Physiological genomics of antidepressant targets: keeping the periphery in mind. J Neurosci 2001; 21: 8319-23.
48. Costigan M, Woolf CJ. Pain: molecular mechanisms. J Pain 2000; 1: 35-44.
49. Woolf CJ, Salter MW. Neuronal plasticity: increasing the gain in pain. Science 2000; 288: 1765-9.
50. Yiangou Y, Facer P, Baecker PA et al. ATP-gated ion channel P2X(3) is increased in human inflammatory bowel disease. Neurogastroenterol Motil 2001; 13: 365-9.
51. Yiangou Y, Facer P, Dyer NH et al. Vanilloid receptor 1 immunoreactivity in inflamed human bowel. Lancet 2001; 357: 1338-9.
52. 3 in human urinary bladder. BJU Int 2001; 87: 774-9.
53. Yiangou Y, Facer P, Smith JA et al. Increased acid-sensing ion channel ASIC-3 in inflamed human intestine. Eur J Gastroenterol Hepatol 2001; 13: 891-6.
54. Woolf CJ. Phenotypic modification of primary sensory neurones: the role of nerve growth factor in the production of persistent pain. Philos Trans R Soc Lond B Biol Sci 1996; 351: 441-8.
55. Sciberras DG, Goldenberg MM, Bolognese JA, James I, Baber NS. Inflammatory responses to intradermal injection of platelet activating factor, histamine and prostaglandin E2 in healthy volunteers: a double blind investigation. Br J Clin Pharmacol 1987; 24: 753-61.
56. Seibert K, Zhang Y, Leahy K et al. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc Natl Acad Sci USA 1994; 91: 12013-7.
57. Chan C, Facer P, Davis J, Smith G, Egerton J, Bountra C, Williams N, Anand P. Sensory fibres expressing capsaicin receptor TRPV1 in patients with rectal hypersensitivity and faecal urgency. Lancet 2003; 361: 385-91.
58. Tympanidis P, Casula MA, Yiangou Y, Terenghi G, Dowd P, Anand P. Increased vanilloid receptor VR1 innervation in vulvodynia. Eur J Pain 2004; 8: 129-33.
59. Matthews PJ, Aziz Q, Facer P, Davis JB, Thompson DG, Anand P. Increased capsaicin receptor TPRV1 nerve fibres in the inflamed human oesophagus. Eur J Gastroenterol Hepatol 2004; 16: 897-902.
60. Yoshida N, Uchiyama K, Kuroda M et al. Interleukin-8 expression in the esophageal mucosa of patients with gastroesophageal reflux disease. Scand J Gastroenterol 2004; 39: 816-22.
61. Woolf CJ. Evidence for a central component of post-injury pain hypersensitivity. Nature 1983; 306: 686-8.
62. Woolf CJ. Generation of acute pain: central mechanisms. Br Med Bull 1991; 47: 523-33.
63. Woolf CJ. An overview of the mechanisms of hyperalgesia. Pulm Pharmacol 1995; 8: 161-7.
64. Woolf CJ, Thompson SW. The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states. Pain 1991; 44: 293-9.
65. Ji RR, Woolf CJ. Neuronal plasticity and signal transduction in nociceptive neurones: implications for the initiation and maintenance of pathological pain. Neurobiol Dis 2001; 8: 1-10.
66. Woolf CJ, Costigan M. Transcriptional and posttranslational plasticity and the generation of inflammatory pain. Proc Natl Acad Sci USA 1999; 96: 7723-30.
67. Neumann S, Doubell TP, Leslie T, Woolf CJ. Inflammatory pain hypersensitivity mediated by phenotypic switch in myelinated primary sensory neurones. Nature 1996; 384: 360-4.
68. Woolf CJ, King AE. Dynamic alterations in the cutaneous mechanoreceptive fields of dorsal horn neurones in the rat spinal cord. J Neurosci 1990; 10: 2717-26.
69. Simone DA, Baumann TK, Collins JG, LaMotte RH. Sensitization of cat dorsal horn neurones to innocuous mechanical stimulation after intradermal injection of capsaicin. Brain Res 1989; 486: 185-9.
70. Woolf CJ, Wall PD. Relative effectiveness of C primary afferent fibers of different origins in evoking a prolonged facilitation of the flexor reflex in the rat. J Neurosci 1986; 6: 1433-42.
71. Gracely RH, Lynch SA, Bennett GJ. Painful neuropathy: altered central processing maintained dynamically by peripheral input. Pain 1992; 51: 175-94.
72. Simone DA, Sorkin LS, Oh U et al. Neurogenic hyperalgesia: central neural correlates in responses of spinothalamic tract neurones. J Neurophysiol 1991; 66: 228-46.
73. Dougherty PM, Willis WD. Enhanced responses of spinothalamic tract neurones to excitatory amino acids accompany capsaicin-induced sensitization in the monkey. J Neurosci 1992; 12: 883-94.
74. Hylden JL, Nahin RL, Traub RJ, Dubner R. Expansion of receptive fields of spinal lamina I projection neurones in rats with unilateral adjuvant-induced inflammation: the contribution of dorsal horn mechanisms. Pain 1989; 37: 229-43.
75. Schaible HG, Grubb BD, Neugebauer V, Oppmann M. The effects of NMDA antagonists on neuronal activity in cat spinal cord evoked by acute inflammation in the knee joint. Eur J Neurosci 1991; 3: 981-991.
76. Willis WD. Long-term potentiation in spinothalamic neurones. Brain Res Brain Res Rev 2002; 40: 202-14.
77. LaMotte RH, Lundberg LE, Torebjork HE. Pain, hyperalgesia and activity in nociceptive C units in humans after intradermal injection of capsaicin. J Physiol 1992; 448: 749-64.
78. Simone DA, Baumann TK, LaMotte RH. Dose-dependent pain and mechanical hyperalgesia in humans after intradermal injection of capsaicin. Pain 1989; 38: 99-107.
79. Koltzenburg M, Lundberg LE, Torebjork HE. Dynamic and static components of mechanical hyperalgesia in human hairy skin. Pain 1992; 51: 207-19.
80. Treede RD, Meyer RA, Raja SN, Campbell JN. Peripheral and central mechanisms of cutaneous hyperalgesia. Prog Neurobiol 1992; 38: 397-421.
81. Staud R, Cannon RC, Mauderli AP, Robinson ME, Price DD, Vierck CJ Jr. Temporal summation of pain from mechanical stimulation of muscle tissue in normal controls and subjects with fibromyalgia syndrome. Pain 2003; 102: 87-95.
82. Schaible HG, Ebersberger A, Von Banchet GS. Mechanisms of pain in arthritis. Ann N Y Acad Sci 2002; 966: 343-54.
83. Stubhaug A, Breivik H, Eide PK, Kreunen M, Foss A. Mapping of punctuate hyperalgesia around a surgical incision demonstrates that ketamine is a powerful suppressor of central sensitization to pain following surgery. Acta Anaesthesiol Scand 1997; 41: 1124-32.
84. Eliav E, Teich S, Benoliel R et al. Large myelinated nerve fiber hypersensitivity in oral malignancy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002; 94: 45-50.
85. Campbell JN, Raja SN, Meyer RA, Mackinnon SE. Myelinated afferents signal the hyperalgesia associated with nerve injury. Pain 1988; 32: 89-94.
86. Burstein R, Cutrer MF, Yarnitsky D. The development of cutaneous allodynia during a migraine attack clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurones in migraine. Brain 2000; 123: 1703-9.
87. Woolf CJ, Mannion RJ. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 1999; 353: 1959-64.
88. Gracely RH, Petzke F, Wolf JM, Clauw DJ. Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis Rheum 2002; 46: 1333-43.
89. Burstein R, Yarnitsky D, Goor-Aryeh I, Ransil BJ, Bajwa ZH. An association between migraine and cutaneous allodynia. Ann Neurol 2000; 47: 614-24.
90. Watkins LR, Maier SF. The pain of being sick: implications of immune-to-brain communication for understanding pain. Annu Rev Psychol 2000; 51: 29-57.
91. Jones MP, Dilley JB, Drossman D, Crowell MD. Brain-gut connections in functional GI disorders: anatomic and physiologic relationships. Neurogastroenterol Motil 2006; 18: 91-103.
92. Almeida TF, Roizenblatt S, Tufik S. Afferent pain pathways: a neuroanatomical review. Brain Res 2004; 1000: 40-56.
93. Ongur D, Price JL. The organization of networks within the orbital and medial prefrontal cortex of rats, monkeys and humans. Cereb Cortex 2000; 10: 206-219.
94. Cervero F, Wolstencroft JH. A positive feedback loop between spinal cord nociceptive pathways and antinociceptive areas of the cat's brain stem. Pain 1984; 20: 125-38.
95. Cervero F, Tattersall J. Cutaneous receptive fields of soamtic and viscerosomatic neurones in the thoracic spinal cord of the cat. J Comp Neurol 1985; 237: 325-32.
96. Tattersall JE, Cervero F, Lumb BM. Viscerosomatic neurones in the lower thoracic spinal cord of the cat: excitations and inhibitions evoked by splanchnic and somatic nerve volleys and by stimulation of brain stem nuclei. J Neurophysiol 1986; 56: 1411-23.
97. Haines DE, Milhailoff GA, Yezierski RP. The spinal cord. In: Haines DE, ed. Fundamental Neuroscience, Vol. 129. New York: Churchill, 1997: 142-58.
98. Foreman RD. Spinal and supra-spinal processing of nociceptive inputs from the urinary bladder and somatic receptive fields. In: Mayer EA, Radbould H, eds. Basic and Clinical Aspects of Chronic Abdominal Pain. San Diego: Elsevier Science Publishers, 1993.
99. Payne WW, Poulton EP. Experiments on visceral sensation. Part II. J Physiol Lond 1928; 65: 157-72.
100. Basbaum A, Fields H. Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. Annu Rev Neurosci 1984; 7: 309-38.
101. Millan M. Descending control of pain. Prog Neurobiol 2002; 66: 355-474.
102. Fields H. State-dependent opioid control of pain. Nat Rev Neurosci 2004; 5: 565-75.
103. Giesler GJ Jr, Liebeskind JC. Inhibition of visceral pain by electrical stimulation of the periaqueductal gray matter. Pain 1976; 2: 43-8.
104. Cervero F, Lumb B, Tattersall J. Supraspinal loops that mediate visceral inputs to thoracic spinal cord neurones in the cat. Neurosci Lett 1985; 56: 189-94.
105. Ness TJ, Gebhart GF. Quantitative comparison of inhibition of visceral and cutaneous spinal nociceptive transmission from the midbrain and medulla in the rat. J Neurophysiol 1987; 58: 850-65.
106. Zhuo M, Gebhart GF. Facilitation and attention of a visceral nociceptive reflex from the rostroventral medulla in the rat. Gastroenterol 2002; 122: 1007-19.
107. Coutinho SV, Urban MO, Gebhart GF. The role of CNS NMDA receptors and nitric oxide in visceral hyperalgesia. Eur J Pharmacol 2001; 429: 319-25.
108. Jasmin L, Rabkin SD, Granato A, Boudah A, Ohara PT. Analgesia and hyperalgesia from GABA-mediated modulation of the cerebral cortex. Nature 2003; 424: 316-20.
109. Rosen A, Lundeberg T, Bytner B, Nylander I. Central changes in nociceptin dynorphin B and Met-enkephalin-Arg-Phe in different models of nociception. Brain Res 2000; 857: 212-8.
110. Collins SM. The immunomodulation of enteric neuromuscular function: implications for motility and inflammatory disorders. Gastroenterology 1996; 111: 1683-99.
111. Al Chaer ED, Lawand NB, Westlund KN, Willis WD. Visceral nociceptive input into the ventral posterolateral nucleus of the thalamus: a new function for the dorsal column pathway. J Neurophysiol 1996; 76: 2661-74.
112. Gwee KA, Collins SM, Read NW et al. Increased rectal mucosal expression of interleukin 1beta in recently acquired post-infectious irritable bowel syndrome. Gut 2003; 52: 523-6.
113. Barbara G, Stanghellini V, De Giorgio R et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology 2004; 126: 693-702.
114. Suzuki R, Furuno T, McKay DM et al. Direct neuritemast cell communication in vitro occurs via the neuropeptide substance P. J Immunol 1999; 163: 2410-5.
115. van der Kleij HP, Ma D, Redegeld FA, Kraneveld AD, Nijkamp FP, Bienenstock J. Functional expression of neurokinin 1 receptors on mast cells induced by IL-4 and stem cell factor. J Immunol 2003; 171: 2074-9.
116. Barbara G, De Giorgio R, Stanghellini V, Cremon C, Corinaldesi R. A role for inflammation in irritable bowel syndrome? Gut 2002; 51 (Suppl. 1): i41-4.
117. Coutinho SV, Su X, Sengupta JN, Gebhart G. Role of sensitised pelvic nerve afferents from the inflamed rat colon in the maintenance of visceral hyperalgesia. Prog Brain Res 2000; 129: 375-87.
118. Blackshaw LA, Gebhart GF. The pharmacology of gastrointestinal nociceptive pathways. Curr Opin Pharmacol 2002; 2: 642-9.
119. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 1997; 389: 816-824.
120. Mezey E, Toth ZE, Cortright DN et al. Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human. Proc Natl Acad Sci USA 2000; 97: 3655-60.
121. Zygmunt PM, Petersson J, Andersson DA et al. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 1999; 400: 452-7.
122. Lysy J, Sistiery-Ittah M, Israelit Y et al. Topical capsaicin - a novel and effective treatment for idiopathic intractable pruritus ani: a randomised, placebo controlled, crossover study. Gut 2003; 52: 1323-6.
123. Bar KJ, Facer P, Williams NS, Tam PK, Anand P. Glial-derived neurotrophic factor in human adult and fetal intestine and in Hirschsprung's disease. Gastroenterology 1997; 112: 1381-5.
124. Bhat YM, Bielefeldt K. Capsaicin receptor (TRPV1) and non-erosive reflux disease. Eur J Gastroenterol Hepatol 2006; 18: 263-70.
125. Bortolotti M, Coccia G, Grossi G, Miglioli M. The treatment of functional dyspepsia with red pepper. Aliment Pharmacol Ther 2002; 16: 1075-82.
126. Drewes AM, Schipper K-P, Dimcevski G et al. Gut pain and hyperalgesia induced by capsaicin: a human experimental model. Pain 2003; 104: 333-41.
127. Schmidt B, Hammer J, Holzer P, Hammer HF. Chemical nociception in the jejunum induced by capsaicin. Gut 2004; 53: 1109-16.
128. di Mola FF, Friess H, Zhu ZW et al. Nerve growth factor and Trk high affinity receptor (TrkA) gene expression in inflammatory bowel disease. Gut 2000; 46: 670-9.
129. Ji R-R, Samad TA, Jin S-X, Schmoll R, Woolf CJ. p38 MAPK Activation by NGF in primary sensory neurones after inflammation increases TRPV1 levels and maintains heat hyperalgesia. Neuron 2002; 36: 57-68.
130. Premkumar LS, Ahern GP. Induction of vanilloid receptor channel activity by protein kinase C. Nature 2000; 408: 985-90.
131. Waldmann R, Champigny G, Bassilana F, Heurteaux C, Lazdunski M. A proton-gated cation channel involved in acid-sensing. Nature 1997; 386: 173-7.
132. North RA, Barnard EA. Nucleotide receptors. Curr Opin Neurobiol 1997; 7: 346-57.
133. Wood JN. Recent advances in understanding molecular mechanisms of primary afferent activation. Gut 2004; 53: ii9-12.
134. Catterall WA. Cellular and molecular biology of voltage-gated sodium channels. Physiol Rev 1992; 72: S15-48.
135. Cervero F. Sensory innervation of the viscera: peripheral basis of visceral pain. Physiol Rev 1994; 74: 95-138.
136. Gebhart GFN, Ness TJ. Visceral pain: a review of experimental studies. Pain 1990; 41: 167-234.
137. Gebhart GF, Ness TJ. Central mechanisms of visceral pain. Can J Physiol Pharmacol 1991; 69: 627-34.
138. Gebhart GF. Pathobiology of visceral pain: molecular mechanisms and therapeutic implications IV. Visceral afferent contributions to the pathobiology of visceral pain. Am J Physiol Gastrointest Liver Physiol 2000; 278: G834-8.
139. Mayer EA, Collins SM. Evolving pathophysiologic models of functional gastrointestinal disorders. Gastroenterology 2002; 122: 2032-48.
140. Sarkar S, Hobson AR, Furlong PL, Woolf CJ, Thompson DG, Aziz Q. Central neural mechanisms mediating human visceral hypersensitivity. Am J Physiol Gastrointest Liver Physiol 2001; 281: G1196-202.
141. Willert RP, Woolf CJ, Hobson AR, Delaney C, Thompson DG, Aziz Q. The Development and maintenance of human visceral pain hypersensitivity is dependent on the N-methly-D-aspartate receptor. Gastroenterology 2004; 126: 683-692.
142. Garrison DW, Chandler MJ, Foreman RD. Viscerosomatic convergence onto feline spinal neurones from esophagus, heart and stomach fields: effects of inflammation. Pain 1992; 49: 373-82.
143. Giamberardino MA, Dalal A, Valente R, Vecchiet L. Changes in activity of spinal cells with muscular input in rats with referred muscular hyperalgesia from ureteral calculosis. Neurosci Lett 1996; 203: 89-92.
144. Miranda A, Peles S, Rudolph C, Shaker R, Sengupta JN. Altered visceral sensation in response to somatic pain in the rat. Gastroenterology 2004; 126: 1082-9.
145. Zhai QZ, Traub RJ. Differential effects of N-methyl-D-aspartate receptor blockade on nociceptive somatic and visceral reflexes. Pain 1999; 83: 321-9.
146. Traub RJ, Zhai Q, Ji Y, Kovalenko M. NMDA receptor antagonists attenuate noxious and nonnoxious colorectal distention-induced Fos expression in the spinal cord and the visceromotor reflex. Neuroscience 2002; 113: 205-11.
147. Labus JS, Bolus R, Chang L et al. The visceral sensitivity index: development and validation of a gastrointestinal symptom-specific anxiety scale. Aliment Pharmacol Ther 2004; 20: 89-97.
148. Schwetz I, Bradesi S, McRoberts JA et al. Delayed stress-induced colonic hypersensitivity in male Wistar rats: role of neurokinin-1 and corticotropin-releasing factor-1 receptors. Am J Physiol Gastrointest Liver Physiol 2004; 286: G683-91.
149. Lechner SM, Curtis AL, Brons R, Valentino RJ. Locus coeruleus activation by colon distention: role of corticotropin-releasing factor and excitatory amino acids. Brain Res 1997; 756: 114-24.
150. Lembo T, Plourde V, Shui Z et al. Effects of the corticotropin-releasing factor (CRF) on rectal afferent nerves in humans. Neurogastroenterol Motil 1996; 8: 9-18.
151. Sagami Y, Shimada Y, Tayama J et al. Effect of a corticotropin releasing hormone receptor antagonist on colonic sensory and motor function in patients with irritable bowel syndrome. Gut 2004; 53: 958-64.
152. Drossman DA. Sexual and physical abuse and gastrointestinal illness. Scand J Gastroenterol Suppl 1995; 208: 90-6.
153. Van Oudenhove L, Vandenberghe J, Geeraerts B, Vos R, Demyttenaere K, Tack J. Influence of anxiety on gastric sensorimotor function in functional dyspepsia. Gastroenterology 2005; 128 (Suppl. 2): A135-6.
154. Geeraerts B, Van Oudenhove L, Fischler B et al. The association between gastric sensorimotor function and abuse history in functional dyspepsia. Gastroenterology 2005; 128 (Suppl. 2): A339.
155. Ringel Y, Whitehead WE, Toner BB et al. Sexual and physical abuse are not associated with rectal hypersensitivity in patients with irritable bowel syndrome. Gut 2004; 53: 838-42.
156. Raphael KG. Childhood abuse and pain in adulthood: more than a modest relationship? Clin J Pain 2005; 21: 371-3.
157. Sykes MA, Blanchard EB, Lackner J, Keefer L, Krasner S. Psychopathology in irritable bowel syndrome: support for a psychophysiological model. J Behav Med 2003; 26: 361-72.
158. Whorwell PJ, Prior A, Faragher EB. Controlled trial of hypnotherapy in the treatment of severe refractory irritable-bowel syndrome. Lancet 1984; 2: 1232-4.
159. Guthrie E, Creed F, Dawson D, Tomenson B. A controlled trial of psychological treatment for the irritable bowel syndrome. Gastroenterology 1991; 100: 450-7.
160. Gonsalkorale WM, Miller V, Afzal A, Whorwell PJ. Long term benefits of hypnotherapy for irritable bowel syndrome. Gut 2003; 52: 1623-9.
161. Urban MO, Gebhart GF. Supraspinal contributions to hyperalgesia. Proc Natl Acad Sci USA 1999; 96: 7687-92.
162. Sandkuhler J, Gebhart GF. Characterization of inhibition of a spinal nociceptive reflex by stimulation medially and laterally in the midbrain and medulla in the pentobarbital-anesthetized rat. Brain Res 1984; 305: 67-76.
163. Mayer EA. Spinal and supraspinal modulation of visceral sensation. Gut 2000; 47: iv69-72, discussion iv76.
164. Derbyshire SWG. A systematic review of neuroimaging data during visceral stimulation. Am J Gastroenterol 2003; 98: 12-20.
165. Dunckley P, Wise RG, Fairhurst M, Hobden P, Aziz Q, Chang L, Tracey I. A comparison of visceral and somatic pain processing in the human brainstem using functional magnetic resonance imaging. J Neurosci 2005; 25: 7333-41.
166. Damasio AR, Grabowski TJ, Bechara A et al. Subcortical and cortical brain activity during the feeling of self-generated emotions. Nat Neurosci 2000; 3: 1049-56.
167. Damasio AR. Looking for Spinoza: Joy, Sorrow and the Feeling Brain. Orlando: Harcourt, 2003: 27-126.
168. Phan KL, Wager TD, Taylor SF, Liberzon I. Functional neuroimaging studies of human emotions. CNS Spectr 2004; 9: 258-66.
169. Mayer EA, Berman S, Suyenobu B et al. Differences in brain responses to visceral pain between patients with irritable bowel syndrome and ulcerative colitis. Pain 2005; 115: 398-409.
170. Naliboff BD, Derbyshire SWG, Munakata J et al. Cerebral activation in patients with irritable bowel syndrome and control subjects during rectosigmoid stimulation. Psychosom Med 2001; 63: 365-75.
171. Mertz H, Morgan V, Tanner G, Pickens D, Price R, Shyr Y, Kessler R. Regional cerebral activation in irritable bowel syndrome and control subjects with painful and nonpainful rectal distention. Gastroenterology 2000; 118: 842-8.
172. Wilder-Smith CH, Schindler D, Lovblad K, Redmond SM, Nirkko A. Brain functional magnetic resonance imaging of rectal pain and activation of endogenous inhibitory mechanisms in irritable bowel syndrome patient subgroups and healthy controls. Gut 2004; 53: 1595-1601.
173. Andresen V, Bach DR, Poellinger A et al. Brain activation responses to subliminal or supraliminal rectal stimuli and to auditory stimuli in irritable bowel syndrome. Neurogastroenterol Motil 2005; 17: 827-37.
174. Kwan CL, Diamant NE, Pope G, Mikula K, Mikulis DJ, Davis KD. Abnormal forebrain activity in functional bowel disorder patients with chronic pain. Neurology 2005; 65: 1268-77.
175. Ringel Y, Drossman DA, Turkington TG et al. Regional brain activation in response to rectal distension in patients with irritable bowel syndrome and the effect of a history of abuse. Dig Dis Sci 2003; 48: 1774-81.
176. Hobson AR, Aziz Q. Brain imaging and functional gastrointestinal disorders: has it helped our understanding? Gut 2004; 53: 1198-206.
177. Lackner JM, Lou Coad M, Mertz HR et al. Cognitive therapy for irritable bowel syndrome is associated with reduced limbic activity, GI symptoms, and anxiety. Behav Res Ther 2006; 44: 621-38.
178. Vandenberghe J, Dupont P, Fischler B, Persoons P, Tack J. Regional brain activation during proximal stomach distention in man: a PET study. Gastroenterology 2005; 128: 564-73.
179. Lu C-L, Wu Y-T, Yeh T-C et al. Neuronal correlates of gastric pain induced by fundus distension: a 3T-fMRI study. Neurogastroenterol Motil 2004; 16: 575-87.
180. Lu C-L, Chang F-Y, Hsieh J-C. Is somatosensory cortex activated during proximal stomach stimulation and the role of insula in visceral pain. Gastroenterology 2005; 128: 1529-30.
181. Van Oudenhove L, Dupont P, Vandenberghe J, Geeraerts B, Tack J. Is somatosensory cortex activated during proximal stomach stimulation and the role of insula in visceral pain - Reply to Lu et al. Gastroenterology 2005; 128: 1530-1.
182. Vandenberghe J, Dupont P, Persoons P, Demyttenaere K, Tack J. Regional cerebral blood flow during gastric balloon distention in functional dyspepsia. Gastroenterology 2003; 124 (Suppl. 2): A29.
183. Phillips M, Gregory L, Cullen S et al. The effect of negative emotional context on neural and behavioural responses to oesophageal stimulation. Brain 2003; 126: 669-684.
184. Whitehead WE, Palsson OS. Is rectal pain sensitivity a biological marker for irritable bowel syndrome: psychological influences on pain perception. Gastroenterology 1998; 115: 1263-71.
185. Sarkar S, Hobson AR, Hughes A et al. The prostaglandin E2 receptor-1 (EP-1) mediates acid-induced visceral pain hypersensitivity in humans. Gastroenterology 2003; 124: 18-25.
186. Malmberg AB, Yaksh TL. Antinociceptive actions of spinal nonsteroidal anti-inflammatory agents on the formalin test in the rat. J Pharmacol Exp Ther 1992; 263: 136-46.
187. Malmberg AB, Yaksh TL. Antinociception produced by spinal delivery of the S and R enantiomers of flurbiprofen in the formalin test. Eur J Pharmacol 1994; 256: 205-9.
188. Willingale HL, Gardiner NJ, McLymont N, Giblett S, Grubb BD. Prostanoids synthesized by cyclo-oxygenase isoforms in rat spinal cord and their contribution to the development of neuronal hyperexcitability. Br J Pharmacol 1997; 122: 1593-604.
189. Yaksh TL, Dirig DM, Conway CM, Svensson C, Luo ZD, Isakson PC. The acute antihyperalgesic action of nonsteroidal, anti-inflammatory drugs and release of spinal prostaglandin E2 is mediated by the inhibition of constitutive spinal cyclooxygenase-2 (COX-2) but not COX-1. J Neurosci 2001; 21: 5847-53.
190. Svensson CI, Yaksh TL. The spinal phospholipase-cyclooxygenase-prostanoid cascade in nociceptive processing. Annu Rev Pharmacol Toxicol 2002; 42: 553-83.
191. Willert RP, Delaney C, Hobson AR, Thompson DG, Woolf CJ, Aziz Q. Constitutive cyclo-oxygenase-2 does not contribute to the development of human visceral pain hypersensitivity. Eur J Pain 2006; 10: 487-94.
192. Vanegas H, Schaible HG. Prostaglandins and cyclooxygenases [correction of cycloxygenases] in the spinal cord. Prog Neurobiol 2001; 64: 327-63.
193. Traub RJ. The spinal contribution of substance P to the generation and maintenance of inflammatory hyperalgesia in the rat. Pain 1996; 67: 151-61.
194. Mantyh PW, Rogers SD, Honore P et al. Inhibition of hyperalgesia by ablation of lamina I spinal neurones expressing the substance P receptor. Science 1997; 278: 275-9.
195. Nichols ML, Allen BJ, Rogers SD et al. Transmission of chronic nociception by spinal neurones expressing the substance P receptor. Science 1999; 286: 1558-61.
196. Laird JMA, Roza C, De Felipe C, Hunt SP, Cervero F. Role of central and peripheral tachykinin NK1 receptors in capsaicin-induced pain and hyperalgesia in mice. Pain 2001; 90: 97-103.
197. Okano S, Nagaya H, Ikeura Y, Natsugari H, Inatomi N. Effects of TAK-637, a novel neurokinin-1 receptor antagonist, on colonic function in vivo. J Pharmacol Exp Ther 2001; 298: 559-64.
198. Greenwood-Van Meerveld B, Gibson MS, Johnson AC, Venkova K, Sutkowski-Markmann D. NK1 receptor-mediated mechanisms regulate colonic hypersensitivity in the guinea pig. Pharmacol Biochem Behav 2003; 74: 1005-13.
199. Boyce S, Hill R. Discrepant results from preclinical and clinical studies on the potential of substance P receptor antagonist compounds as analgesics. In: Devor M, Rowbotham MC, Wiesenfeld-Hallin Z, eds. Proceedings of the 9th World Congress on Pain. Progress in Pain Research and Management, Vol. 16. Seattle: IASP Press, 2000.
200. De Felipe C, Herrero JF, O'Brien JA et al. Altered nociception, analgesia and aggression in mice lacking the receptor for substance P. Nature 1998; 392: 394-7.
201. Zimmer A, Zimmer AM, Baffi J et al. Hypoalgesia in mice with a targeted deletion of the tachykinin 1 gene. Proc Natl Acad Sci USA 1998; 95: 2630-5.
202. Perry MJ, Lawson SN. Differences in expression of oligosaccharides, neuropeptides, carbonic anhydrase and neurofilament in rat primary afferent neurones retrogradely labelled via skin, muscle or visceral nerves. Neuroscience 1998; 85: 293-310.
203. Brown JL, Liu H, Maggio JE, Vigna SR, Mantyh PW, Basbaum AI. Morphological characterization of substance P receptor-immunoreactive neurones in the rat spinal cord and trigeminal nucleus caudalis. J Comp Neurol 1995; 356: 327-44.
204. Willert RP, Delaney C, Hobson AR, Hicks KJ, Dewit OE, Aziz Q. Human visceral pain hypersensitivity is not attenuated by neurokinin-1 (NK-1) receptor antagonism. Gastroenterology 2006; 130 (Suppl 2): A26-A27. (abstract).
205. Kirkup AJ, Brunsden AM, Grundy D. Receptors and transmission in the brain-gut axis: potential for novel therapies. I. Receptors on visceral afferents. Am J Physiol Gastrointest Liver Physiol 2001; 280: G787-94.
206. Hornby PJ, Prouty SM. Involvement of cannabinoid receptors in gut motility and visceral perception. Br J Pharmacol 2004; 141: 1335-45.